nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—migraine—Prednisone—systemic scleroderma	0.8	1	CpDpCtD
Cyproheptadine—HTR2B—cardial valve—systemic scleroderma	0.019	0.391	CbGeAlD
Cyproheptadine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0058	0.119	CbGeAlD
Cyproheptadine—HTR2A—pulmonary artery—systemic scleroderma	0.00411	0.0844	CbGeAlD
Cyproheptadine—UGT1A3—digestive system—systemic scleroderma	0.0026	0.0534	CbGeAlD
Cyproheptadine—HTR2A—artery—systemic scleroderma	0.00152	0.0313	CbGeAlD
Cyproheptadine—HTR2A—endothelium—systemic scleroderma	0.00129	0.0264	CbGeAlD
Cyproheptadine—HTR2A—blood vessel—systemic scleroderma	0.00119	0.0244	CbGeAlD
Cyproheptadine—HTR2B—smooth muscle tissue—systemic scleroderma	0.00104	0.0214	CbGeAlD
Cyproheptadine—HTR2B—skin of body—systemic scleroderma	0.00103	0.0211	CbGeAlD
Cyproheptadine—CHRM3—smooth muscle tissue—systemic scleroderma	0.000937	0.0193	CbGeAlD
Cyproheptadine—HTR2B—digestive system—systemic scleroderma	0.000822	0.0169	CbGeAlD
Cyproheptadine—HTR2B—tendon—systemic scleroderma	0.000783	0.0161	CbGeAlD
Cyproheptadine—CHRM3—digestive system—systemic scleroderma	0.00074	0.0152	CbGeAlD
Cyproheptadine—HRH1—connective tissue—systemic scleroderma	0.000728	0.015	CbGeAlD
Cyproheptadine—CHRM1—lung—systemic scleroderma	0.00069	0.0142	CbGeAlD
Cyproheptadine—HTR2B—lung—systemic scleroderma	0.000687	0.0141	CbGeAlD
Cyproheptadine—HRH1—smooth muscle tissue—systemic scleroderma	0.000666	0.0137	CbGeAlD
Cyproheptadine—SLC6A2—lung—systemic scleroderma	0.00061	0.0125	CbGeAlD
Cyproheptadine—HTR2A—connective tissue—systemic scleroderma	0.000608	0.0125	CbGeAlD
Cyproheptadine—HTR2A—smooth muscle tissue—systemic scleroderma	0.000556	0.0114	CbGeAlD
Cyproheptadine—DRD2—lung—systemic scleroderma	0.000556	0.0114	CbGeAlD
Cyproheptadine—HRH1—digestive system—systemic scleroderma	0.000526	0.0108	CbGeAlD
Cyproheptadine—HRH1—tendon—systemic scleroderma	0.0005	0.0103	CbGeAlD
Cyproheptadine—Thrombocytopenia—Captopril—systemic scleroderma	0.000477	0.00316	CcSEcCtD
Cyproheptadine—Tachycardia—Captopril—systemic scleroderma	0.000476	0.00315	CcSEcCtD
Cyproheptadine—Leukopenia—Azathioprine—systemic scleroderma	0.000467	0.00309	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.000465	0.00308	CcSEcCtD
Cyproheptadine—Anorexia—Captopril—systemic scleroderma	0.000465	0.00307	CcSEcCtD
Cyproheptadine—Vision blurred—Leflunomide—systemic scleroderma	0.000464	0.00307	CcSEcCtD
Cyproheptadine—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.000462	0.00306	CcSEcCtD
Cyproheptadine—Asthenia—Pentoxifylline—systemic scleroderma	0.000461	0.00305	CcSEcCtD
Cyproheptadine—Tension—Mycophenolic acid—systemic scleroderma	0.000461	0.00305	CcSEcCtD
Cyproheptadine—Nervousness—Mycophenolic acid—systemic scleroderma	0.000456	0.00302	CcSEcCtD
Cyproheptadine—Hypotension—Captopril—systemic scleroderma	0.000455	0.00301	CcSEcCtD
Cyproheptadine—Tinnitus—Lisinopril—systemic scleroderma	0.000453	0.003	CcSEcCtD
Cyproheptadine—Increased appetite—Prednisone—systemic scleroderma	0.000444	0.00294	CcSEcCtD
Cyproheptadine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000443	0.00293	CcSEcCtD
Cyproheptadine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000443	0.00293	CcSEcCtD
Cyproheptadine—Vertigo—Leflunomide—systemic scleroderma	0.000442	0.00293	CcSEcCtD
Cyproheptadine—Insomnia—Captopril—systemic scleroderma	0.000441	0.00292	CcSEcCtD
Cyproheptadine—Leukopenia—Leflunomide—systemic scleroderma	0.000441	0.00292	CcSEcCtD
Cyproheptadine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00044	0.00291	CcSEcCtD
Cyproheptadine—Tremor—Mycophenolic acid—systemic scleroderma	0.00044	0.00291	CcSEcCtD
Cyproheptadine—HTR2A—digestive system—systemic scleroderma	0.000439	0.00903	CbGeAlD
Cyproheptadine—HRH1—lung—systemic scleroderma	0.000439	0.00903	CbGeAlD
Cyproheptadine—Paraesthesia—Captopril—systemic scleroderma	0.000438	0.0029	CcSEcCtD
Cyproheptadine—Chills—Lisinopril—systemic scleroderma	0.000436	0.00288	CcSEcCtD
Cyproheptadine—Palpitations—Leflunomide—systemic scleroderma	0.000435	0.00288	CcSEcCtD
Cyproheptadine—Somnolence—Captopril—systemic scleroderma	0.000433	0.00287	CcSEcCtD
Cyproheptadine—Agitation—Mycophenolic acid—systemic scleroderma	0.000432	0.00286	CcSEcCtD
Cyproheptadine—Dyspepsia—Captopril—systemic scleroderma	0.000429	0.00284	CcSEcCtD
Cyproheptadine—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000426	0.00282	CcSEcCtD
Cyproheptadine—Dizziness—Pentoxifylline—systemic scleroderma	0.000425	0.00281	CcSEcCtD
Cyproheptadine—Decreased appetite—Captopril—systemic scleroderma	0.000424	0.0028	CcSEcCtD
Cyproheptadine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000424	0.0028	CcSEcCtD
Cyproheptadine—Vertigo—Mycophenolic acid—systemic scleroderma	0.000422	0.00279	CcSEcCtD
Cyproheptadine—Syncope—Mycophenolic acid—systemic scleroderma	0.000421	0.00279	CcSEcCtD
Cyproheptadine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00042	0.00278	CcSEcCtD
Cyproheptadine—Fatigue—Captopril—systemic scleroderma	0.00042	0.00278	CcSEcCtD
Cyproheptadine—HTR2A—tendon—systemic scleroderma	0.000418	0.00859	CbGeAlD
Cyproheptadine—Constipation—Captopril—systemic scleroderma	0.000417	0.00276	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000417	0.00276	CcSEcCtD
Cyproheptadine—Tension—Lisinopril—systemic scleroderma	0.000415	0.00275	CcSEcCtD
Cyproheptadine—Palpitations—Mycophenolic acid—systemic scleroderma	0.000415	0.00275	CcSEcCtD
Cyproheptadine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000413	0.00273	CcSEcCtD
Cyproheptadine—Nervousness—Lisinopril—systemic scleroderma	0.000411	0.00272	CcSEcCtD
Cyproheptadine—Vomiting—Pentoxifylline—systemic scleroderma	0.000409	0.00271	CcSEcCtD
Cyproheptadine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000407	0.00269	CcSEcCtD
Cyproheptadine—Rash—Pentoxifylline—systemic scleroderma	0.000406	0.00268	CcSEcCtD
Cyproheptadine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000405	0.00268	CcSEcCtD
Cyproheptadine—Headache—Pentoxifylline—systemic scleroderma	0.000403	0.00267	CcSEcCtD
Cyproheptadine—Feeling abnormal—Captopril—systemic scleroderma	0.000402	0.00266	CcSEcCtD
Cyproheptadine—Vision blurred—Lisinopril—systemic scleroderma	0.000399	0.00264	CcSEcCtD
Cyproheptadine—Asthenia—Mometasone—systemic scleroderma	0.000398	0.00263	CcSEcCtD
Cyproheptadine—Irritability—Prednisone—systemic scleroderma	0.000398	0.00263	CcSEcCtD
Cyproheptadine—Hypotension—Azathioprine—systemic scleroderma	0.000397	0.00263	CcSEcCtD
Cyproheptadine—Photosensitivity—Methotrexate—systemic scleroderma	0.000397	0.00263	CcSEcCtD
Cyproheptadine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000397	0.00263	CcSEcCtD
Cyproheptadine—Tremor—Lisinopril—systemic scleroderma	0.000396	0.00262	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000393	0.0026	CcSEcCtD
Cyproheptadine—Tachycardia—Leflunomide—systemic scleroderma	0.000392	0.00259	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000388	0.00257	CcSEcCtD
Cyproheptadine—Hepatic failure—Methotrexate—systemic scleroderma	0.000388	0.00257	CcSEcCtD
Cyproheptadine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000386	0.00256	CcSEcCtD
Cyproheptadine—Oedema—Mycophenolic acid—systemic scleroderma	0.000383	0.00254	CcSEcCtD
Cyproheptadine—Anorexia—Leflunomide—systemic scleroderma	0.000383	0.00253	CcSEcCtD
Cyproheptadine—Nausea—Pentoxifylline—systemic scleroderma	0.000382	0.00253	CcSEcCtD
Cyproheptadine—Chills—Mycophenolate mofetil—systemic scleroderma	0.000382	0.00253	CcSEcCtD
Cyproheptadine—Vertigo—Lisinopril—systemic scleroderma	0.00038	0.00251	CcSEcCtD
Cyproheptadine—Diarrhoea—Mometasone—systemic scleroderma	0.00038	0.00251	CcSEcCtD
Cyproheptadine—Syncope—Lisinopril—systemic scleroderma	0.000379	0.00251	CcSEcCtD
Cyproheptadine—Leukopenia—Lisinopril—systemic scleroderma	0.000379	0.00251	CcSEcCtD
Cyproheptadine—Shock—Mycophenolic acid—systemic scleroderma	0.000377	0.0025	CcSEcCtD
Cyproheptadine—Hypotension—Leflunomide—systemic scleroderma	0.000375	0.00248	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000375	0.00248	CcSEcCtD
Cyproheptadine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000374	0.00248	CcSEcCtD
Cyproheptadine—Palpitations—Lisinopril—systemic scleroderma	0.000374	0.00247	CcSEcCtD
Cyproheptadine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000372	0.00246	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00037	0.00245	CcSEcCtD
Cyproheptadine—HTR2A—lung—systemic scleroderma	0.000367	0.00754	CbGeAlD
Cyproheptadine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000365	0.00242	CcSEcCtD
Cyproheptadine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000364	0.00241	CcSEcCtD
Cyproheptadine—Insomnia—Leflunomide—systemic scleroderma	0.000363	0.0024	CcSEcCtD
Cyproheptadine—Paraesthesia—Leflunomide—systemic scleroderma	0.000361	0.00239	CcSEcCtD
Cyproheptadine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00036	0.00238	CcSEcCtD
Cyproheptadine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000358	0.00237	CcSEcCtD
Cyproheptadine—Dyspepsia—Leflunomide—systemic scleroderma	0.000354	0.00234	CcSEcCtD
Cyproheptadine—Vomiting—Mometasone—systemic scleroderma	0.000353	0.00233	CcSEcCtD
Cyproheptadine—Sweating increased—Prednisone—systemic scleroderma	0.000351	0.00232	CcSEcCtD
Cyproheptadine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000351	0.00232	CcSEcCtD
Cyproheptadine—Rash—Mometasone—systemic scleroderma	0.00035	0.00232	CcSEcCtD
Cyproheptadine—Asthenia—Captopril—systemic scleroderma	0.00035	0.00231	CcSEcCtD
Cyproheptadine—Dermatitis—Mometasone—systemic scleroderma	0.00035	0.00231	CcSEcCtD
Cyproheptadine—Decreased appetite—Leflunomide—systemic scleroderma	0.000349	0.00231	CcSEcCtD
Cyproheptadine—Confusional state—Lisinopril—systemic scleroderma	0.000348	0.0023	CcSEcCtD
Cyproheptadine—Headache—Mometasone—systemic scleroderma	0.000348	0.0023	CcSEcCtD
Cyproheptadine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000347	0.0023	CcSEcCtD
Cyproheptadine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000347	0.00229	CcSEcCtD
Cyproheptadine—Fatigue—Leflunomide—systemic scleroderma	0.000346	0.00229	CcSEcCtD
Cyproheptadine—Oedema—Lisinopril—systemic scleroderma	0.000345	0.00228	CcSEcCtD
Cyproheptadine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000344	0.00228	CcSEcCtD
Cyproheptadine—Constipation—Leflunomide—systemic scleroderma	0.000344	0.00227	CcSEcCtD
Cyproheptadine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000341	0.00225	CcSEcCtD
Cyproheptadine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000341	0.00225	CcSEcCtD
Cyproheptadine—Shock—Lisinopril—systemic scleroderma	0.00034	0.00225	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000338	0.00224	CcSEcCtD
Cyproheptadine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000337	0.00223	CcSEcCtD
Cyproheptadine—Tachycardia—Lisinopril—systemic scleroderma	0.000337	0.00223	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000334	0.00221	CcSEcCtD
Cyproheptadine—Diarrhoea—Captopril—systemic scleroderma	0.000334	0.00221	CcSEcCtD
Cyproheptadine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000333	0.0022	CcSEcCtD
Cyproheptadine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000333	0.0022	CcSEcCtD
Cyproheptadine—Irritability—Methotrexate—systemic scleroderma	0.000333	0.0022	CcSEcCtD
Cyproheptadine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000332	0.0022	CcSEcCtD
Cyproheptadine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000332	0.0022	CcSEcCtD
Cyproheptadine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000331	0.00219	CcSEcCtD
Cyproheptadine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00033	0.00219	CcSEcCtD
Cyproheptadine—Nausea—Mometasone—systemic scleroderma	0.00033	0.00218	CcSEcCtD
Cyproheptadine—Anorexia—Lisinopril—systemic scleroderma	0.000329	0.00218	CcSEcCtD
Cyproheptadine—Weight increased—Prednisone—systemic scleroderma	0.000328	0.00217	CcSEcCtD
Cyproheptadine—Constipation—Mycophenolic acid—systemic scleroderma	0.000328	0.00217	CcSEcCtD
Cyproheptadine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000327	0.00217	CcSEcCtD
Cyproheptadine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000326	0.00216	CcSEcCtD
Cyproheptadine—Hypotension—Lisinopril—systemic scleroderma	0.000323	0.00213	CcSEcCtD
Cyproheptadine—Dizziness—Captopril—systemic scleroderma	0.000322	0.00213	CcSEcCtD
Cyproheptadine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000321	0.00212	CcSEcCtD
Cyproheptadine—Urticaria—Leflunomide—systemic scleroderma	0.000319	0.00211	CcSEcCtD
Cyproheptadine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000316	0.00209	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000315	0.00209	CcSEcCtD
Cyproheptadine—Insomnia—Lisinopril—systemic scleroderma	0.000312	0.00207	CcSEcCtD
Cyproheptadine—Paraesthesia—Lisinopril—systemic scleroderma	0.00031	0.00205	CcSEcCtD
Cyproheptadine—Vomiting—Captopril—systemic scleroderma	0.00031	0.00205	CcSEcCtD
Cyproheptadine—Rash—Captopril—systemic scleroderma	0.000307	0.00203	CcSEcCtD
Cyproheptadine—Dermatitis—Captopril—systemic scleroderma	0.000307	0.00203	CcSEcCtD
Cyproheptadine—Somnolence—Lisinopril—systemic scleroderma	0.000307	0.00203	CcSEcCtD
Cyproheptadine—Headache—Captopril—systemic scleroderma	0.000305	0.00202	CcSEcCtD
Cyproheptadine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000305	0.00202	CcSEcCtD
Cyproheptadine—Dyspepsia—Lisinopril—systemic scleroderma	0.000304	0.00201	CcSEcCtD
Cyproheptadine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000302	0.002	CcSEcCtD
Cyproheptadine—Decreased appetite—Lisinopril—systemic scleroderma	0.0003	0.00199	CcSEcCtD
Cyproheptadine—Fatigue—Lisinopril—systemic scleroderma	0.000298	0.00197	CcSEcCtD
Cyproheptadine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000298	0.00197	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000296	0.00196	CcSEcCtD
Cyproheptadine—Constipation—Lisinopril—systemic scleroderma	0.000295	0.00195	CcSEcCtD
Cyproheptadine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000295	0.00195	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000292	0.00193	CcSEcCtD
Cyproheptadine—Diarrhoea—Azathioprine—systemic scleroderma	0.000291	0.00193	CcSEcCtD
Cyproheptadine—Nausea—Captopril—systemic scleroderma	0.00029	0.00192	CcSEcCtD
Cyproheptadine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000288	0.00191	CcSEcCtD
Cyproheptadine—Asthenia—Leflunomide—systemic scleroderma	0.000288	0.00191	CcSEcCtD
Cyproheptadine—Hallucination—Prednisone—systemic scleroderma	0.000287	0.0019	CcSEcCtD
Cyproheptadine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000284	0.00188	CcSEcCtD
Cyproheptadine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000283	0.00187	CcSEcCtD
Cyproheptadine—Dizziness—Azathioprine—systemic scleroderma	0.000281	0.00186	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000275	0.00182	CcSEcCtD
Cyproheptadine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000275	0.00182	CcSEcCtD
Cyproheptadine—Diarrhoea—Leflunomide—systemic scleroderma	0.000275	0.00182	CcSEcCtD
Cyproheptadine—Urticaria—Lisinopril—systemic scleroderma	0.000274	0.00181	CcSEcCtD
Cyproheptadine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000274	0.00181	CcSEcCtD
Cyproheptadine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000272	0.0018	CcSEcCtD
Cyproheptadine—Vomiting—Azathioprine—systemic scleroderma	0.00027	0.00179	CcSEcCtD
Cyproheptadine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000269	0.00178	CcSEcCtD
Cyproheptadine—Drowsiness—Methotrexate—systemic scleroderma	0.000269	0.00178	CcSEcCtD
Cyproheptadine—Rash—Azathioprine—systemic scleroderma	0.000268	0.00177	CcSEcCtD
Cyproheptadine—Dermatitis—Azathioprine—systemic scleroderma	0.000268	0.00177	CcSEcCtD
Cyproheptadine—Headache—Azathioprine—systemic scleroderma	0.000266	0.00176	CcSEcCtD
Cyproheptadine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000266	0.00176	CcSEcCtD
Cyproheptadine—Dizziness—Leflunomide—systemic scleroderma	0.000266	0.00176	CcSEcCtD
Cyproheptadine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000263	0.00174	CcSEcCtD
Cyproheptadine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000262	0.00174	CcSEcCtD
Cyproheptadine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000259	0.00171	CcSEcCtD
Cyproheptadine—Vomiting—Leflunomide—systemic scleroderma	0.000255	0.00169	CcSEcCtD
Cyproheptadine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000253	0.00168	CcSEcCtD
Cyproheptadine—Rash—Leflunomide—systemic scleroderma	0.000253	0.00168	CcSEcCtD
Cyproheptadine—Dermatitis—Leflunomide—systemic scleroderma	0.000253	0.00167	CcSEcCtD
Cyproheptadine—Nausea—Azathioprine—systemic scleroderma	0.000253	0.00167	CcSEcCtD
Cyproheptadine—Headache—Leflunomide—systemic scleroderma	0.000252	0.00167	CcSEcCtD
Cyproheptadine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000251	0.00166	CcSEcCtD
Cyproheptadine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000249	0.00165	CcSEcCtD
Cyproheptadine—Asthenia—Lisinopril—systemic scleroderma	0.000248	0.00164	CcSEcCtD
Cyproheptadine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000244	0.00161	CcSEcCtD
Cyproheptadine—Rash—Mycophenolic acid—systemic scleroderma	0.000242	0.0016	CcSEcCtD
Cyproheptadine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000241	0.0016	CcSEcCtD
Cyproheptadine—Hepatitis—Methotrexate—systemic scleroderma	0.000241	0.0016	CcSEcCtD
Cyproheptadine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00024	0.00159	CcSEcCtD
Cyproheptadine—Headache—Mycophenolic acid—systemic scleroderma	0.00024	0.00159	CcSEcCtD
Cyproheptadine—Nausea—Leflunomide—systemic scleroderma	0.000239	0.00158	CcSEcCtD
Cyproheptadine—Vision blurred—Prednisone—systemic scleroderma	0.000237	0.00157	CcSEcCtD
Cyproheptadine—Diarrhoea—Lisinopril—systemic scleroderma	0.000236	0.00156	CcSEcCtD
Cyproheptadine—Agitation—Prednisone—systemic scleroderma	0.000231	0.00153	CcSEcCtD
Cyproheptadine—Dizziness—Lisinopril—systemic scleroderma	0.000228	0.00151	CcSEcCtD
Cyproheptadine—Nausea—Mycophenolic acid—systemic scleroderma	0.000228	0.00151	CcSEcCtD
Cyproheptadine—Vertigo—Prednisone—systemic scleroderma	0.000226	0.00149	CcSEcCtD
Cyproheptadine—Syncope—Prednisone—systemic scleroderma	0.000225	0.00149	CcSEcCtD
Cyproheptadine—Tinnitus—Methotrexate—systemic scleroderma	0.000225	0.00149	CcSEcCtD
Cyproheptadine—Loss of consciousness—Prednisone—systemic scleroderma	0.000221	0.00146	CcSEcCtD
Cyproheptadine—Vomiting—Lisinopril—systemic scleroderma	0.000219	0.00145	CcSEcCtD
Cyproheptadine—Rash—Lisinopril—systemic scleroderma	0.000218	0.00144	CcSEcCtD
Cyproheptadine—Convulsion—Prednisone—systemic scleroderma	0.000218	0.00144	CcSEcCtD
Cyproheptadine—Dermatitis—Lisinopril—systemic scleroderma	0.000217	0.00144	CcSEcCtD
Cyproheptadine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000217	0.00144	CcSEcCtD
Cyproheptadine—Chills—Methotrexate—systemic scleroderma	0.000216	0.00143	CcSEcCtD
Cyproheptadine—Headache—Lisinopril—systemic scleroderma	0.000216	0.00143	CcSEcCtD
Cyproheptadine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000207	0.00137	CcSEcCtD
Cyproheptadine—Nausea—Lisinopril—systemic scleroderma	0.000205	0.00136	CcSEcCtD
Cyproheptadine—Oedema—Prednisone—systemic scleroderma	0.000205	0.00136	CcSEcCtD
Cyproheptadine—Shock—Prednisone—systemic scleroderma	0.000202	0.00133	CcSEcCtD
Cyproheptadine—Tachycardia—Prednisone—systemic scleroderma	0.0002	0.00132	CcSEcCtD
Cyproheptadine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.0002	0.00132	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000198	0.00131	CcSEcCtD
Cyproheptadine—Vision blurred—Methotrexate—systemic scleroderma	0.000198	0.00131	CcSEcCtD
Cyproheptadine—Anorexia—Prednisone—systemic scleroderma	0.000195	0.00129	CcSEcCtD
Cyproheptadine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000192	0.00127	CcSEcCtD
Cyproheptadine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000191	0.00126	CcSEcCtD
Cyproheptadine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000191	0.00126	CcSEcCtD
Cyproheptadine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000189	0.00125	CcSEcCtD
Cyproheptadine—Vertigo—Methotrexate—systemic scleroderma	0.000189	0.00125	CcSEcCtD
Cyproheptadine—Leukopenia—Methotrexate—systemic scleroderma	0.000188	0.00124	CcSEcCtD
Cyproheptadine—Insomnia—Prednisone—systemic scleroderma	0.000185	0.00123	CcSEcCtD
Cyproheptadine—Paraesthesia—Prednisone—systemic scleroderma	0.000184	0.00122	CcSEcCtD
Cyproheptadine—Convulsion—Methotrexate—systemic scleroderma	0.000182	0.0012	CcSEcCtD
Cyproheptadine—Dyspepsia—Prednisone—systemic scleroderma	0.00018	0.00119	CcSEcCtD
Cyproheptadine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00018	0.00119	CcSEcCtD
Cyproheptadine—Decreased appetite—Prednisone—systemic scleroderma	0.000178	0.00118	CcSEcCtD
Cyproheptadine—Fatigue—Prednisone—systemic scleroderma	0.000177	0.00117	CcSEcCtD
Cyproheptadine—Constipation—Prednisone—systemic scleroderma	0.000175	0.00116	CcSEcCtD
Cyproheptadine—Confusional state—Methotrexate—systemic scleroderma	0.000173	0.00114	CcSEcCtD
Cyproheptadine—Feeling abnormal—Prednisone—systemic scleroderma	0.000169	0.00112	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000168	0.00111	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000166	0.0011	CcSEcCtD
Cyproheptadine—Anorexia—Methotrexate—systemic scleroderma	0.000163	0.00108	CcSEcCtD
Cyproheptadine—Urticaria—Prednisone—systemic scleroderma	0.000163	0.00108	CcSEcCtD
Cyproheptadine—Hypotension—Methotrexate—systemic scleroderma	0.00016	0.00106	CcSEcCtD
Cyproheptadine—Insomnia—Methotrexate—systemic scleroderma	0.000155	0.00103	CcSEcCtD
Cyproheptadine—Paraesthesia—Methotrexate—systemic scleroderma	0.000154	0.00102	CcSEcCtD
Cyproheptadine—Somnolence—Methotrexate—systemic scleroderma	0.000152	0.00101	CcSEcCtD
Cyproheptadine—Dyspepsia—Methotrexate—systemic scleroderma	0.000151	0.000998	CcSEcCtD
Cyproheptadine—Decreased appetite—Methotrexate—systemic scleroderma	0.000149	0.000986	CcSEcCtD
Cyproheptadine—Fatigue—Methotrexate—systemic scleroderma	0.000148	0.000977	CcSEcCtD
Cyproheptadine—Asthenia—Prednisone—systemic scleroderma	0.000147	0.000973	CcSEcCtD
Cyproheptadine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000141	0.000934	CcSEcCtD
Cyproheptadine—Diarrhoea—Prednisone—systemic scleroderma	0.00014	0.000928	CcSEcCtD
Cyproheptadine—Urticaria—Methotrexate—systemic scleroderma	0.000136	0.000901	CcSEcCtD
Cyproheptadine—Dizziness—Prednisone—systemic scleroderma	0.000136	0.000897	CcSEcCtD
Cyproheptadine—Vomiting—Prednisone—systemic scleroderma	0.00013	0.000863	CcSEcCtD
Cyproheptadine—Rash—Prednisone—systemic scleroderma	0.000129	0.000855	CcSEcCtD
Cyproheptadine—Dermatitis—Prednisone—systemic scleroderma	0.000129	0.000855	CcSEcCtD
Cyproheptadine—Headache—Prednisone—systemic scleroderma	0.000128	0.00085	CcSEcCtD
Cyproheptadine—Asthenia—Methotrexate—systemic scleroderma	0.000123	0.000813	CcSEcCtD
Cyproheptadine—Nausea—Prednisone—systemic scleroderma	0.000122	0.000806	CcSEcCtD
Cyproheptadine—Diarrhoea—Methotrexate—systemic scleroderma	0.000117	0.000776	CcSEcCtD
Cyproheptadine—Dizziness—Methotrexate—systemic scleroderma	0.000113	0.00075	CcSEcCtD
Cyproheptadine—Vomiting—Methotrexate—systemic scleroderma	0.000109	0.000721	CcSEcCtD
Cyproheptadine—Rash—Methotrexate—systemic scleroderma	0.000108	0.000715	CcSEcCtD
Cyproheptadine—Dermatitis—Methotrexate—systemic scleroderma	0.000108	0.000714	CcSEcCtD
Cyproheptadine—Headache—Methotrexate—systemic scleroderma	0.000107	0.00071	CcSEcCtD
Cyproheptadine—Nausea—Methotrexate—systemic scleroderma	0.000102	0.000673	CcSEcCtD
